Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
RESEARCH TOOLSreports
RVL Pharmaceuticals (RVLPQ) Stock Price & Analysis
309 Followers
RVLPQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $1.05
Previous Close$0.01
Volume155.00
Average Volume (3M)N/A
Market Cap
$11.14K
Enterprise Value$38.96M
Total Cash (Recent Filing)$19.20M
Total Debt (Recent Filing)$58.15M
Price to Earnings (P/E)>-0.1
Beta4.46
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding99,535,197
10 Day Avg. Volume14,777
30 Day Avg. VolumeN/A
Standard Deviation0.31
R-Squared0.02
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00100
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit0.97
Enterprise Value/Ebitda-0.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RVL Pharmaceuticals News
PremiumCompany Announcements
RVL Pharmaceuticals Ordered to Liquidate by Irish High Court
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RVLPQ FAQ
What was RVL Pharmaceuticals’s price range in the past 12 months?
RVL Pharmaceuticals lowest stock price was <$0.01 and its highest was $1.05 in the past 12 months.
What is RVL Pharmaceuticals’s market cap?
Currently, no data Available
When is RVL Pharmaceuticals’s upcoming earnings report date?
RVL Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 10 days.
How were RVL Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is RVL Pharmaceuticals overvalued?
According to Wall Street analysts RVL Pharmaceuticals’s price is currently Overvalued.
Does RVL Pharmaceuticals pay dividends?
RVL Pharmaceuticals does not currently pay dividends.
What is RVL Pharmaceuticals’s EPS estimate?
RVL Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RVL Pharmaceuticals have?
RVL Pharmaceuticals has 111,406,044 shares outstanding.
What happened to RVL Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RVL Pharmaceuticals?
Among the largest hedge funds holding RVL Pharmaceuticals’s share is Blackstone Inc.. It holds RVL Pharmaceuticals’s shares valued at N/A.
---
RVL Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
RVL Pharmaceuticals
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development and commercialization of specialty products for neurology and women's health. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
---
RVLPQ Earnings Call
Q2 2023
0:00 / 0:00
---
RVLPQ Stock 12 Months Forecast
Average Price Target
―---